CNS Pharmaceuticals, Inc. (CNSP)

CIK 1729427 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for CNS Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Aug 25, 2026DEFA14A0001683168-26-006724
Aug 21, 2026DEF 14A0001683168-26-006660
Aug 18, 202640001683168-26-006553
Aug 18, 202630001683168-26-006551
Aug 18, 202640001683168-26-006552
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352973
Aug 12, 202610-Q0001683168-26-006224
Jul 2, 20268-K0001683168-26-005233
May 26, 2026424B30001683168-26-004304
May 26, 2026EFFECT9999999995-26-001762
May 20, 202640001683168-26-004145
May 19, 2026S-30001683168-26-004123
May 19, 2026D0001683168-26-004126
May 15, 2026SCHEDULE 13G/A0000935836-26-000277
May 14, 202610-Q0001683168-26-003847
May 4, 20268-K0001683168-26-003432
Apr 30, 202610-K/A0001683168-26-003374
Apr 17, 2026SCHEDULE 13G0001193125-26-161735
Mar 31, 202610-K0001683168-26-002550
Mar 11, 20268-K0001683168-26-001664
Mar 4, 202630001683168-26-001488
Mar 4, 202640001683168-26-001491
Mar 4, 202630001683168-26-001490
Mar 4, 202640001683168-26-001489
Mar 2, 20268-K0001683168-26-001413